Concetta Conticello

9PUBLICATIONS
58CO-AUTHORS
Haematological tumoursAutoimmunityGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 18, 2026
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

|Apr 14, 2026
FcγRIIIA Genotype in Plasma Cell Dyscrasias Is Associated with Clinical Progression, Bone Disease Extension and Immune Dysfunction.

Daniela Cambria, Maria Teresa Cannizzaro, Nunziatina Laura Parrinello

|Feb 26, 2026
Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients-A Survey from Two Italian Centers.

Vittorio Del Fabro, Lara Gullo, Giuliana Giunta

|Jul 12, 2025
COVID-19 Vaccine Experience: Loss of Humoral Response Following Autologous Stem Cell Transplantation in Multiple Myeloma Patients and Positive Effect of Booster Dose.

Uros Markovic, Elvira Scalisi, Giuliana Giunta

|Jun 27, 2025
Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18, 595.

Nicola Sgherza, Olga Battisti, Paola Curci

|Apr 26, 2025
Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study.

Nicola Sgherza, Olga Battisti, Paola Curci

Pageof 2

Frequent Collaborators

3 joint publications

Pellegrino Musto

3 joint publications

Uros Markovic

3 joint publications

Manlio Fazio

3 joint publications

Vittorio Del Fabro